Whatcom County Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
(NQ: )
N/A   UNCHANGED
Last Price  /  Updated:   /  Add to My Watchlist      
View: Quote News
Blog posts about
 
< Previous 1 2 3 4 5 6 7 8 Next >
Cost Control Helps Amylin Cut Loss
January 27, 2011
Amylin Pharmaceuticals (NASDAQ:AMLN) reported a net loss of 8 cents per share in the fourth quarter of 2010, well below the Zacks Consensus Estimate and the year-ago loss of 32 cents. Full year 2010... Read More
category AMLN , ALKS , USA , and 5 more.
from DailyMarkets.com
Traders prefer calls on AMLN, and puts on ONXX
January 12, 2011
Options players are taking sides on Amylin Pharmaceuticals, Inc. (AMLN) and Onyx Pharmaceuticals, Inc...( Read More ) Read More
category AMLN
from SchaeffersResearch.com Market Observations
Rolling BLA For AMLN’s Metreleptin
December 21, 2010
Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) recently announced that it has initiated the filing of a rolling Biologics License Application (BLA) for metreleptin. The company is seeking US Food and Drug... Read More
category AMLN , ALKS , USA , and 4 more.
from DailyMarkets.com
(AMLN) Amylin Pharmaceuticals Analyst Maintains Neutral
December 20, 2010
We recently reiterated our Neutral recommendation on Amylin Pharmaceuticals, Inc. (AMLN). Amylin reported a net loss of $0.31 per share in the third quarter of 2010, three cents below the Zacks... Read More
category AMLN , Biotechnology , ALKS , and 5 more.
from Stock Blog Hub
Options Players High on Drug Stocks: Amylin Pharmaceuticals and InterMune
December 10, 2010
It seems that speculators are taking their cues from precocious teen star Miley Cyrus -- yesterday, it was beer; today, they've moved on to the harder stuff...( Read More ) Read More
category AMLN
from SchaeffersResearch.com Trading Floor Blog
(ALKS) Alkermes 2010 Second Quarter Revenues Rise – View Lowered
November 25, 2010
Alkermes Inc.’s (ALKS) second quarter fiscal 2011 net loss (excluding special items) of 6 cents per share compared unfavorably with the year-ago loss of 5 cents per share. The Zacks Consensus Estimate... Read More
category AMLN , JNJ , ALKS , and 7 more.
from Stock Blog Hub
Amylin Stays Neutral
November 24, 2010
We recently reiterated our Neutral recommendation on Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN). Amylin reported a net loss of $0.31 per share in the third quarter of 2010, three cents below the Zacks... Read More
category AMLN , ALKS , USA , and 4 more.
from DailyMarkets.com
(JNJ) Pharma & Biotech Industry Outlook – November 2010 – Industry Outlook
November 15, 2010
With 2010 coming to an end, the pharmaceutical industry continues to witness major challenges like sluggish prescription trends, EU pricing pressure, intensifying generic competition and limited... Read More
category Glaxosmithkline plc , ALKS , GENZ , and 41 more.
from Stock Blog Hub
(AMLN) Amylin Pharmaceuticals Reports Wider Loss
November 12, 2010
Amylin Pharmaceuticals (AMLN) reported a net loss of 31 cents per share in the third quarter of 2010, three cents below the Zacks Consensus Estimate but well above the year-earlier loss of 19 cents.... Read More
category AMLN , Biotechnology , ALKS , and 7 more.
from Stock Blog Hub
Revenues Rise At ALKS, View Lowered
November 08, 2010
Alkermes Inc.’s (NASDAQ:ALKS) second quarter fiscal 2011 net loss (excluding special items) of 6 cents per share compared unfavorably with the year-ago loss of 5 cents per share. The Zacks Consensus... Read More
category AMLN , jnj , ALKS , and 5 more.
from DailyMarkets.com
Earnings on Deck: Amylin Pharmaceuticals, Hoku Corporation, and ReneSola Ltd.
November 04, 2010
There's no shortage of earnings left to digest before the trading week wraps up...( Read More ) Read More
category AMLN
from SchaeffersResearch.com Trading Floor Blog
Upgrades / Downgrades (AEP, AMLN, BBT, COG, CHKP, CML, JKS, MRT, BJRI, CI, EXC, FE, KOG, PNR, PEG, RCI, SDRL)
October 27, 2010
New York, October 27th (TradersHuddle.com) – Following are some of the top upgrades and downgrades before the market open. Upgrades American Electric Power (NYSE:. Read More -- Read More
from TradersHuddle.com
Upgrades / Downgrades (AEP, AMLN, BBT, COG, CHKP, CML, JKS, MRT, BJRI, CI, EXC, FE, KOG, PNR, PEG, RCI, SDRL)
October 27, 2010
New York, October 27th (TradersHuddle.com) – Following are some of the top upgrades and downgrades before the market open. Upgrades American Electric Power (NYSE:. Read More -- Read More
from TradersHuddle.com
Jim Cramer’s Sell Block Video: Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN), Alkermes, Inc. (NASDAQ:ALKS), MannKind Corporation (NASDAQ:MNKD)
October 26, 2010
category Uncategorized
from Madd Money
Rude Shock For Amylin
October 20, 2010
Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) suffered a huge setback recently when the US Food and Drug Administration (FDA) issued a second complete response letter (CRL) for Bydureon, Amylin’s main... Read More
category AMLN , ALKS , USA , and 5 more.
from DailyMarkets.com
Upgrades / Downgrades (CFN, CSBC, HUBG, JNPR, TWIN, VMW, AMLN, KOF, LLY, FSII, WFR, OXY, WFT)
October 20, 2010
New York, October 20th (TradersHuddle.com) – Following are some of the top upgrades and downgrades before the market open. Upgrades CareFusion Corp. (NYSE:CFN),. Read More -- Read More
from TradersHuddle.com
(ALKS) Alkermes’ Vivitrol Earns US Food and Drug Administration Clearance
October 17, 2010
Alkermes Inc. (ALKS) received a boost when the US Food and Drug Administration (FDA) cleared its drug Vivitrol (naltrexone for extended-release injectable suspension) for the prevention of relapse to... Read More
category AMLN , ALKS , LLY , and 5 more.
from Stock Blog Hub
FDA Nod For Alkermes’ Vivitrol
October 15, 2010
Alkermes Inc. (NASDAQ:ALKS) received a boost when the US Food and Drug Administration (FDA) cleared its drug Vivitrol (naltrexone for extended-release injectable suspension) for the prevention of... Read More
category AMLN , ALKS , USA , and 4 more.
from DailyMarkets.com
(BMY) Bristol-Myers Squibb’s Pipeline Advances
October 15, 2010
Bristol-Myers Squibb Company’s (BMY) pipeline received a boost when its type II diabetes candidate, dapagliflozin, fared well in a late-stage multicenter, active-controlled, randomized, parallel-group,... Read More
category AZN , AMLN , JNJ , and 13 more.
from Stock Blog Hub
(BMY) Bristol-Myers Squibb Trial Presents Encouraging Data
October 04, 2010
Recently, Bristol-Myers Squibb Company’s (BMY) pipeline received a boost when its type II diabetes candidate, dapagliflozin, fared well in a late-stage multicenter, active-controlled, randomized,... Read More
category AZN , AMLN , JNJ , and 13 more.
from Stock Blog Hub
Call Writers Capitalize on Amylin Pharmaceuticals, Inc.'s Technical Stagnation
September 27, 2010
Amylin Pharmaceuticals, Inc. (AMLN) was the target of a bullish brokerage note from Jefferies this morning...( Read More ) Read More
category AMLN
from SchaeffersResearch.com Daily Market Blog
BMY Presents Encouraging Data
September 27, 2010
Recently, Bristol-Myers Squibb Company’s (NYSE:BMY) pipeline received a boost when its type II diabetes candidate, dapagliflozin, fared well in a late-stage multicenter, active-controlled, randomized,... Read More
category AZN , AMLN , External Research , and 9 more.
from DailyMarkets.com
(BMY) Bristol-Myers Squibb Company Diabetes Drug Candidate Encourages
September 21, 2010
Recently, Bristol-Myers Squibb Company’s (BMY) pipeline received a boost when its type II diabetes candidate, dapagliflozin, fared well in a late-stage multicenter, international, randomized,... Read More
category AZN , AMLN , JNJ , and 13 more.
from Stock Blog Hub
BMY’s Diabetes Candidate Encourages
September 21, 2010
Recently, Bristol-Myers Squibb Company’s (NYSE:BMY) pipeline received a boost when its type II diabetes candidate, dapagliflozin, fared well in a late-stage multicenter, international, randomized,... Read More
category AMLN , Eurozone , SNY , and 5 more.
from DailyMarkets.com
Thumbs Up For ALKS Drug
September 17, 2010
Recently, Alkermes Inc. (NASDAQ:ALKS) received a boost when an advisory panel of the US Food and Drug Administration (FDA) recommended the approval of Vivitrol (naltrexone for extended-release... Read More
category AMLN , ALKS , USA , and 4 more.
from DailyMarkets.com
(ALKS) Alkermes Earnings Report Shows Revenues Dipped
August 10, 2010
Alkermes Inc.’s (ALKS) first-quarter fiscal 2011 net loss of 14 cents per share compared unfavorably with the year-ago loss of 2 cents per share. The Zacks Consensus Estimate was a loss of 14 cents per... Read More
category AMLN , Glaxosmithkline plc , JNJ , and 11 more.
from Stock Blog Hub
Revenues Dip At Alkermes
August 09, 2010
Alkermes Inc.’s (NASDAQ:ALKS) first-quarter fiscal 2011 net loss of  14 cents per share compared unfavorably with the year-ago loss of 2 cents per share. The Zacks Consensus Estimate was a loss of 14... Read More
category AMLN , ALKS , External Research , and 7 more.
from DailyMarkets.com
Traders are favoring puts on AMLN, and calls on MBI
August 03, 2010
Looking over the past week's worth of option volume, it seems that traders are taking sides on Amylin Pharmaceuticals, Inc...( Read More ) Read More
category AMLN
from SchaeffersResearch.com Market Observations
Option Skews - Relatively Heavy Put Activity for Amylin Pharmaceuticals Inc., Nokia Corp., Consol Energy Inc., Express Scripts Inc.
July 29, 2010
Here are the stocks that saw a bias toward put activity in the previous session...( Read More ) Read More
category AMLN
from SchaeffersResearch.com Trading Floor Blog
(ABT) Pharma and Biotech Industry Outlook – July 2010 – Analyst Interviews
July 26, 2010
The pharmaceutical industry has witnessed major changes over the past few quarters, with performance being affected by factors like sluggish prescription trends, intensifying generic competition and... Read More
category Glaxosmithkline plc , ALKS , GENZ , and 45 more.
from Stock Blog Hub
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here